22 mars 2016 - FDA requires a new boxed warning about the serious risks of misuse and abuse, which can lead to addiction, overdose and death. The FDA also requires several additional safety labeling changes across all prescription opioid products to include additional information on the risk of these medications.
Ajouté au bande de temps:
Date:
22 mars 2016
Maintenaint
~ Il y a 9 ans et 7 mois